Home/Filings/4/0001209191-23-004224
4//SEC Filing

Carter Martha J. 4

Accession 0001209191-23-004224

CIK 0001322505other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:05 PM ET

Size

5.7 KB

Accession

0001209191-23-004224

Insider Transaction Report

Form 4
Period: 2023-01-19
Carter Martha J.
Chief Regulatory Officer
Transactions
  • Sale

    Common Stock

    2023-01-19$43.90/sh938$41,18214,626 total
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.90 to $43.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]Represents 3,432 shares of common stock and 11,194 restricted stock units.

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeother

Related Parties

1
  • filerCIK 0001213040

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:05 PM ET
Size
5.7 KB